PEDEVCO CORP. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by PEDEVCO Corp. on August 31, 2023. The filing primarily reports on the results of the Company's 2023 Annual Meeting of Stockholders held on the same date and the granting of restricted stock awards to non-employee directors.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on corporate governance and equity compensation events.
Material Changes and Corporate Actions
- Director Elections: Stockholders elected three director nominees: John J. Scelfo, Simon Kukes, and H. Douglas Evans. All nominees were elected by a plurality of votes cast with no opposition.
- Auditor Ratification: Stockholders ratified the appointment of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
- Executive Compensation: Stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2023.
- Equity Grants: On August 31, 2023, the Company granted restricted stock under the 2021 Equity Incentive Plan:
- 125,000 shares to Chairman John Scelfo (vesting July 12, 2024).
- 85,000 shares to Director H. Douglas Evans (vesting September 27, 2024).
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors. It notes that the voting results should be read in connection with the Definitive Proxy Statement on Schedule 14A filed on July 13, 2023.
Investor Verification Checklist
- Verify the full text of the Restricted Shares Grant Agreement (Exhibit 99.3 to Form S-8) for specific vesting conditions and forfeiture provisions.
- Review the Definitive Proxy Statement (Schedule 14A) filed on July 13, 2023, for detailed background on the director nominees and executive compensation packages.
- Confirm the total number of outstanding shares (87,040,267 as of the July 3, 2023 record date) to assess the dilution impact of the new equity grants.
- Check subsequent filings for the Company's audited financial results for the fiscal year ending December 31, 2023, as this 8-K does not contain financial statements.